|
Hintz RJ, Johnson KC. The effect of particle
size distribution on dissolution rate and oral absorption. Int J Pharm. 51
(1989) 9-17.
Sheng JJ, Sirois PJ, Dressman JB, Amidon GL.
Particle Diffusional Layer Thickness in a USP Dissolution Apparatus II: A
Combined Function of Particle Size and Paddle Speed. J Pharm Sci. Published
online ahead of print.
Okazaki A, Mano T, Sugano K. Theoretical
Dissolution Model of Poly-Disperse Drug Particles in Biorelevant Media. J
Pharm Sci. 97 (2008) 1843-1852.
Gao L, Zhang D, Chen
M, Duan C, Dai W, Jia L, Zhao W. Studies on pharmacokinetics and tissue
distribution of oridonin nanosuspensions. Int J Pharm. Article in Press.
Simon LL, Introvigne M, Fischer U,
Hungerbűhler. Batch reactor optimization under liquid swelling safety
constraint. Chemical Engineering Science. 63 (2008) 770-781.
Sugano K, Okazaki A, Sugimoto S, Tavornvipas
S, Omura A, Mano T. Solubility and dissolution profile assessment in drug
discovery. Drug Metab Pharmacokinet. 22 (2007) 225-254.
Takano R, Sugano K, Higashida A, Hayashi Y,
Machida M, Aso Y, Yamashita S. Oral Absorption of Poorly
Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a
Miniscale Dissolution Test. Pharm Res. 23 (2006) 1144-56.
Simon LL, Fischer U, Hungerbuhler K. Modeling
of a three-phase industrial batch reactor using a hybrid first-principles
neural-network model. Ind Eng Chem Res. 45 (2006) 7336-7343.
Cabri W, Ghetti P, Alpegiani M, Pozzi G,
Justo-Erbez A, Perez-Martinez JI, Villalon-Rubio R, Monedero-PeralesMC,
Munoz-Ruiz A. Cefdinir: a comparative study of anhydrous vs. monohydrate form
- microstructure and tabletting behaviour. European Journal of Pharmaceutics
and Biopharmaceutics. 64 (2006) 212-221.
Galli C. Experimental determination of the
diffusion boundary layer width of micron and submicron particles. Int J Pharm.
313 (2006) 114-122.
Jinno J, Kamada N, Miyake M, Yamada K, Mukai
T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. Effect of particle
size reduction on dissolution and oral absorption of a poorly water-soluble
drug, cilostazol, in beagle dogs. J Control Release. 111 (2006) 56-64.
Mansbach RS, Moore RA. Formulation
considerations for the development of medications with abuse potential. Drug
and Alcohol Dependence. 83 (supplement 1) (2006) S15-S22.
Hecq J. Deleers M, Fanara D, Vranckx H,
Amighi K. Preparation and characterization of nanocrystals for solubility and
dissolution rate enhancement of nifedipine. Int J Pharm.
299 (2005) 167-77.
Tinke AP, Vanhoutte K, De Maesschalck R, Verheyen S, De Winter H.
A new approach in the prediction of the
dissolution behavior of suspended particles by means of their particle size
distribution. J Pharm Biomed Anal.
39 (2005) 900-7.
Sertsou G.
Analytical derivation of time
required for dissolution of monodisperse drug particles. J Pharm Sci. 93
(2004) 1941-4.
Bosch HW, Skapin SD,
Matijevic E. Preparation and characterization of finely dispersed drugs. 5.
Ethyl 3,5-di(acetylamino)-2,4,6-triiodobenzoate. Colloids and Surfaces A:
Physicochem. Eng. Aspects. 250 (2004) 43-50.
Balbach S, Korn C.
Pharmceutical evaluation of early development candidates "the 100
mg-approach". Int J Pharm. 275 (2004) 1-12.
Lansky P, Lanska V, Weiss
M. A stochastic differential equation model for drug dissolution and its
parameters. Journal of Controlled Release. 100 (2004) 267-274.
Fiese EF. General pharmaceutics - The new
physical pharmacy. J Pharm Sci. 92 (2003) 1331-1342.
Laitinen
N. Opening new perspectives for visual characterisation of pharmaceutical
solids. Doctoral dissertation 2003. University of Helsinki, Faculty of Science,
Department of Pharmacy.
Shan GU, Igarashi K, Ooshima H. Dissolution kinetics of crystals in suspension and its application
to L-aspartic acid crystals. Chem Eng J. 288 (2002) 53-8.
Chambin O, Berard V,
Rochat-Gonthier MH, Pourcelot Y. Dry absorbed emulsion: 2. Dissolution
behaviour of an intricate formulation. Int J Pharm. 235 (2002) 169-178.
Lee MS, Huang CL, Huang SH, Chen YP, Chen CJ, Wen KC. A comparative study
on the dissolution profiles of commercial hydrochlorothiazide tablets. Journal
of Food and Drug Analysis 10 (2002) 18-24.
Friend DR, Parry GE, Francis T, Kupperblatt G,
Chrai SS, Slack G. Mathematical modeling of a novel controlled-release dosage
form. Drug Delivery Technology 1 (2001) 36-43.
Yu LX. An integrated model for determining
causes of poor oral drug absorption. Pharm Res 16 (1999) 1883-7.
Lee MS, Chang YC, Shih CC, et al. Study on
dissolution profile of commercial glyburide tablets. J Food Drug Anal. 7
(1999) 83-93.
Carstensen JT, Dali M. Particle size
distributions in mesh cuts and microscopically estimated volumetric shape
factors. Drug Dev Ind Pharm. 25 (1999) 347-52.
Kalampokis A, Argyrakis P, Macheras P.
Heterogeneous tube model for the study of small intestinal flow. Pharm Res.
16 (1999) 87-91.
Dali MV, Carstensen JT. Particle size
distributions from multiparticulate dissolution. Drug Dev Ind Pharm. 24
(1998) 637-44.
Curatolo W. Physical chemical properties of oral
drug candidates in the discovery and exploratory development settings. PSTT.
1 (1998) 387-93.
Pereira De Almeida L, Simões S, Brito P,
Portugal A, Figueiredo M. Modeling dissolution of sparingly soluble
multisized powders. J Pharm Sci. 86 (1997) 726-32.
Chakrabarti S, Southard MZ. Control of poorly
soluble drug dissolution in conditions simulating the gastrointestinal tract
flow. 2. Cocompression of drugs with buffers. J Pharm Sci. 86 (1997)
465-69.
Simões S, Pereira de Almeida L, Figueiredo M.
Testing the applicability of classical diffusional models to polydisperse
systems. Int J Pharm. 139, (1996) 169-76.
Tromelin A, Habillon S, Andrés C, Pourcelot Y,
Chaillot B. Relationship between particle size and dissolution rate of bulk
powders and sieving characterized fractions of two qualities of orthoboric
acid. Drug Dev Ind Pharm. 22 (9&10) (1996) 977-86.
de Villiers MM. Influence of agglomeration of
cohesive particles on the dissolution behaviour of furosemide powder. Int J
Pharm. 136 (1996) 175-9.
Yu LX, Crison JR, Amidon GL. Compartmental
transit and dispersion model analysis of small intestinal transit flow in
humans. Int J Pharm. 140 (1996) 111-8.
Yu LX, E Lipka, Crison JR, Amidon GL. Transport
approaches to the biopharmaceutical design of oral drug delivery systems:
prediction of intestinal absorption. Adv Drug Del Rev. 19 (1996)
359-76.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A
theoretical basis for a biopharmaceutic drug classification: the correlation
of in vitro drug product dissolution and in vivo
bioavailability. Pharm Res. 12 (1995) 413-20.
Ueda S, Yamaguchi H, Kotani M, Kimura S,
Tokunaga Y, Kagayama A, Hata T. Development of a novel drug release system,
time-controlled explosion system (TES). II. Design of multiparticulate TES and
in vitro drug release properties. Chem Pharm Bull. 42 (2) (1994)
359-63.
Birat M, Anderberg EK, Barnett MI, Nyström C.
Physicochemical aspects of drug release. XV. Investigation of diffusional
transport in dissolution of suspended, sparingly soluble drugs. Int J Pharm.
80 (1992) 191-201.
Farin D, Avnir D. Use of fractal geometry to
determine effects of surface morphology on drug dissolution. J Pharm Sci.
81 (1992) 54-7.
Book citations
Johansson
F, Paterson R. Chapter 21 - Physiologically Based in Silico Models for the
Prediction of Oral Drug Absorption. Drug Absorption Studies. ed.
Ehrhardt C, Kim KJ. 2008 Springer ISBN 9780387749006.
Johnson KC. Chapter 1 - Dissolution: Fundamentals of In Vitro Release and
the Biopharmaceutics Classification System. Pharmaceutical Product
Development In Vitro-In Vivo Correlation. ed. Chilukuri DM, Sunkara G,
Young D. 2007 Informa Health Care. ISBN 0849338271.
Ungell AL, Abrahamsson B. Chapter 4 - Biopharmaceutical Support in
Candidate Drug Selection. Pharmaceutical Preformulation and
Formulation: A Practical Guide from Candidate Drug Selection to
Commercial Dosage Form. Gibson M editor. 2004 Informa Health Care. ISBN 1574911201.
Granero GE, Ramachandran C, Amidon GL. Chapter 8
- Gastrointestinal Dissolution and Absorption of Drugs. Drug
Bioavailability: Estimation of Solubility, Permeability, Absorption and
Bioavailability. ed. van de
Waterbeemd H, Lennernas H, Artursson P. 2003
Wiley-VCH. ISBN 352730438X.
Yu LX, Ellison CD, Hussain AS. Predicting Human Oral Bioavailability using
In Silico Models. Applications of Pharmacokinetic
Principles in Drug Development. ed. Krishna R. 2003 Springer. ISBN 0306477661.
Carstensen JT. Advanced Pharmaceutical Solids.
2001 CRC Press. ISBN 0824704312.
Dressman JB. Oral Drug Absorption: Prediction
and Assessment. 2000 Informa Health Care. ISBN 0824702727.
Crison JR. Chapter 5 - Biopharmaceutical Aspects
of Water-Insoluble Drugs for Oral Drug Delivery. Water-Insoluble Drug
Formulation. ed.
Liu R. 2000 CRC Press. ISBN 1574911058.
McNamara DP, Vieira ML, Crison JR. Chapter 5 -
Dissolution of Pharmaceuticals in Simple and Complex Systems. Transport
Processes in Pharmaceutical Systems. ed.
Amidon GL, Lee PI, Topp EM. 2000
CRC Press. ISBN 0824766105.
Yu LX, Gatlin L, Amidon GL. Chapter 10 -
Predicting Oral Drug Absorption. Transport Processes in Pharmaceutical
Systems. ed. Amidon GL, Lee PI, Topp EM. 2000 CRC Press. ISBN 0824766105.
Inskeep PB, Darrington RT. Chapter 1 - Utilization of biopharmaceutical
and pharmacokinetic principles in the development of veterinary controlled
release drug delivery systems. Controlled Release Veterinary Drug Delivery:
Biological and Pharmaceutical Considerations. ed. Rathbone MJ, Gurny R.
2000 Elsevier Science.
Sinko CM. Chapter 14 - Granulation
Characterization: Methods and Significance. Handbook of Pharmaceutical
Granulation Technology. ed.
Parikh DM. 1997 Marcel Dekker. ISBN
0824798821.
Randall CS. Chapter 6 - Particle Size
Distribution.
Physical Characterization of Pharmaceutical Solids.
Brittain HG. 1995 Informa Health Care. ISBN 0824793722.
Wagner JG. Pharmacokinetics for the
Pharmaceutical Scientist. 1993 CRC Press. ISBN 1566760321.
Banakar U.
Pharmaceutical Dissolution Testing. 1991 Informa Healthcare. ISBN
0824785673.
Lu ATK, Frisella ME, Johnson KC. Dissolution
modeling: factors affecting the dissolution rates of polydisperse powders.
Pharm Res. 10 (1993) 1308-14.
Sheng JJ, Sirois PJ, Dressman JB, Amidon GL.
Particle Diffusional Layer Thickness in a USP Dissolution Apparatus II: A
Combined Function of Particle Size and Paddle Speed. J Pharm Sci. Published
online ahead of print.
Sugano K, Okazaki A, Sugimoto S, Tavornvipas S,
Omura A, Mano T. Solubility and dissolution profile assessment in drug
discovery. Drug Metab Pharmacokinet. 22 (2007) 225-254.
Mangin D, Garcia E, Gerard S, Hoff C, Klein JP,
Veesler S. Modeling of the dissolution of a pharmaceutical compound. J Cryst
Growth 286 (2006) 121-125.
Jinno J, Kamada N, Miyake M, Yamada K, Mukai
T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. Effect of particle
size reduction on dissolution and oral absorption of a poorly water-soluble
drug, cilostazol, in beagle dogs. J Control Release. 111 (2006) 56-64.
Hecq J. Deleers M, Fanara D, Vranckx H,
Amighi K. Preparation and characterization of nanocrystals for solubility and
dissolution rate enhancement of nifedipine. Int J Pharm.
299 (2005) 167-77.
Sertsou G.
Analytical derivation of time required for
dissolution of monodisperse drug particles. J Pharm Sci. 93 (2004)
1941-4.
Horkovics-Kovats S. Characterization of an active pharmaceutical ingredient
by its dissolution properties: amoxicillin trihydrate as a model drug.
Chemotherapy 50 (2004) 234-44.
Fiese EF. General pharmaceutics - The new
physical pharmacy. J Pharm Sci. 92 (2003) 1331-1342.
Shan GU, Igarashi K,
Ooshima H. Dissolution kinetics of crystals in suspension and its application
to L-aspartic acid crystals. Chem Eng J. 288 (2002) 53-8.
Wang JZ, Flanagan DR. General solution for
diffusion-controlled dissolution of spherical particles. 1. Theory. J Pharm Sci.
88 (1999) 731-8.
Curatolo W. Physical chemical properties of oral
drug candidates in the discovery and exploratory development settings. PSTT.
1 (1998) 387-93.
Okimoto K, Miyake M, Ibuki R, et al. Dissolution
mechanism and rate of solid dispersion particles of nilvadipine with
hydroxypropylmethylcellulose. Int J Pharm. 159 (1997) 85-93.
Pereira De Almeida L, Simões S, Brito P, Portugal
A, Figueiredo M. Modeling dissolution of sparingly soluble multisized powders. J
Pharm Sci. 86 (1997) 726-32.
Simões S, Pereira de Almeida L, Figueiredo M.
Testing the applicability of classical diffusional models to polydisperse
systems. Int J Pharm. 139, (1996) 169-76.
de Villiers MM. Influence of agglomeration of
cohesive particles on the dissolution behaviour of furosemide powder. Int J
Pharm. 136 (1996) 175-9.
Dali MV, Carstensen JT. Effect of change in shape
factor of a single crystal on its dissolution behavior. Pharm Res. 13
(1996) 155-62.
Book citations
Johnson KC. Chapter 1 - Dissolution: Fundamentals of In Vitro Release and
the Biopharmaceutics Classification System. Pharmaceutical Product
Development In Vitro-In Vivo Correlation. ed. Chilukuri DM, Sunkara G,
Young D. 2007 Informa Health Care. ISBN 0849338271.
Water-Insoluble Drug Formulation. ed. Liu
R. 2000 CRC Press. ISBN 1574911058.
Dressman JB. Oral Drug Absorption: Prediction
and Assessment. 2000 Informa Health Care. ISBN 0824702727.
Yu LX, Gatlin L, Amidon GL. Chapter 10 -
Predicting Oral Drug Absorption. Transport Processes in Pharmaceutical
Systems. ed. Amidon GL, Lee PI, Topp EM. 2000 CRC Press. ISBN 0824766105.
Inskeep PB, Darrington RT. Chapter 1 - Utilization of biopharmaceutical
and pharmacokinetic principles in the development of veterinary controlled
release drug delivery systems. Controlled Release Veterinary Drug Delivery:
Biological and Pharmaceutical Considerations. ed. Rathbone MJ, Gurny R.
2000 Elsevier Science.
Macheras P, Reppas C, Dressman JB.
Biopharmaceutics of Orally Administered Drugs. 1995 Ellis Horwood Limited.
ISBN 0131080938.
Wagner JG. Pharmacokinetics for the
Pharmaceutical Scientist. 1993 CRC Press. ISBN 1566760321.
Johnson KC, Swindell AC. Guidance in the
setting of drug particle size specifications to minimize variability in
absorption. Pharm Res. 13 (1996) 1795-8.
Okazaki A, Mano T, Sugano K. Theoretical
Dissolution Model of Poly-Disperse Drug Particles in Biorelevant Media. J Pharm
Sci. 97 (2008) 1843-1852.
Avdeef A, Kansy M, Bendels S, Tsinman K. Absorption-excipient-pH
classification gradient maps: Sparingly soluble drugs and the pH partition
hypothesis. Eur J Pharm Sci. 33 (2008) 29-41.
Yamashita T, Dohta Y,
Nakamura T, Fukami T. High-speed solubility screening assay using
ultra-performance liquid chromatography/mass spectrometry in drug discovery.
Journal of Chromatography A. 1182 (2008) 72-76.
Alsenz J, Kansy M. High throughput solubility
measurement in drug discovery and development. Advanced Drug Delivery Reviews.
59 (2007) 546-567.
Sugano K, Okazaki A, Sugimoto S, Tavornvipas S,
Omura A, Mano T. Solubility and dissolution profile assessment in drug
discovery. Drug Metab Pharmacokinet. 22 (2007) 225-254.
Fagerholm U. Prediction of human
pharmacokinetics - gastrointestinal absorption. Journal of Pharmacy and
Pharmacology. 59 (2007) 905-916.
Maas J, Kamm W, Hauck G. An integrated early
formulation strategy - from hit evaluation to preclinical candidate profiling.
European Journal of Pharmaceutics and Biopharmaceutics. 66 (2007) 1-10.
Stegemann S, Leveiller F, Franchi D, de Jong H,
Linden H. When poor solubility becomes an issue: from early stage to proof of
concept. European Journal of Pharmaceutical Sciences. 31 (2007) 249-261.
Remenar JF. Improving oral bioavailability through inhibition of
crystallization after dosing. American Pharmaceutical Review. 10(2)
(2007) 84-9.
Grabowski T.
Farmakokinetyka i Biofarmacja.
www.biokinetica.pl/farmakokinetyka.pdf
Yalkowsky SH, Johnson JLH, Sanghvi T, Machatha
SG. A ‘Rule of Unity’ for Human Intestinal Absorption. Pharm Res. 23
(2006) 2475-81.
Thomas
VH, Bhattachar S, Hitchingham L, Zocharski P, Naath M, Surendran N, Stoner CL,
El-Kattan A. The road map to oral bioavailability: an industrial perspective.
Expert Opin Drug Metab Toxicol. 2 (2006) 591-606.
Renslo
AR,
Luehr
GW,
Gordeev
MF.
Recent
developments in the identification of novel oxazolidinone antibacterial agents.
Bioorg Med Chem.
14 (2006) 4227-40.
United States Patent
7026508 (2006).
Valko K, Reynolds DP. High-throughput physicochemical and in vitro ADMET
screening. Am J Drug Deliv. 3 (2005) 83-100.
Li S, He H, Parthiban LJ,
Yin H, Serajuddin ATM. IV-IVC considerations in the
development of immediate-release oral dosage form. J Pharm Sci. 94 (2005)
1396-1417.
Tinke
AP, Vanhoutte K, Vanhoutte F, De Smet M, De Winter H. Laser
diffraction and image analysis as a supportive analytical tool in the
pharmaceutical development of immediate release direct compression formulations. Int
J Pharm. 297 (2005) 80-8.
Avdeef
A. The rixe of PAMPA.
Expert Opin Drug Metab Toxicol. 1 (2005) 325-342.
Avdeef A.
Modelling drug absorption with the MAD model, based on permeability and
solubility. Clin Exp Pharm Phys. (Suppl) (2004) A29.
Neervannan S.
Stategies to impact solubility and dissolution rate during drug lead
optimization: salt selection and prodrug design approaches. American
Pharmaceutical Review. 7 (2004) 108-13.
Poggesi I. Predicting human pharmacokinetics
from preclinical data.
Curr Opin Drug Discov Devel. 7 (2004) 100-111.
Rasenack N, Muller BW. Micron-size drug
particles: common and novel micronization techniques.
Pharm Dev Technol. 9 (2004) 1-13.
Huang
LF, Tong WQ. Impact of solid state
properties on developability assessment of drug candidates.
Adv Drug Deliv Rev, 56
(2004) 321-34.
Singhal D, Curatolo W. Drug polymorphism and
dosage form design: a practical perspective.
Adv Drug Deliv Rev.
56 (2004) 335-347.
Faassen WA. Biopharmaceutical aspects of oral drug delivery. Doctoral
thesis. Utrecht University. 2004.
Martini LG, Crowley PJ. Physicochemical approaches to enhancing oral
absorption. Pharmaceutical Technology Europe. Sep 1 2004.
United States Patent
20040044241 (2004).
Tolle-Sander S, Grill A, Joshi H, Kapil R,
Persiani S, Polli JE. Characterization of dexloxiglumide in vitro
biopharmaceutical properties and active transport. J Pharm Sci. 92 (2003)
1968-80.
Sanghvi T, Ni N, Mayersohn M, Yalkowsky SH.
Predicting Passive Intestinal Absorption Using A Single Parameter. QSAR &
Combinatorial Science. 22 (2003) 247-257.
Hilgers AR, Smith DP, Biermacher JJ, Day JS,
Jensen JL, Sims SM, Adams WJ, Friis JM, Palandra J, Hosley JD, Shobe EM, Burton
PS. Predicting Oral Absorption of Drugs: A Case Study with a Novel Class of
Antimicrobial Agents. Pharm Res. 20 (2003) 1149-1155.
Fiese EF. General pharmaceutics - The new
physical pharmacy. J Pharm Sci. 92 (2003) 1331-1342.
Gombar VK, Silver IS, Zhao Z. Role of ADME
Characteristics in Drug Discovery and Their In Silico Evaluation: In Silico
Screening of Chemicals for their Metabolic Stability. Curr Top Med Chem. 3
(2003) 1205-1225.
Bergstrom CAS, Strafford M, Lazorova L, Avdeef
A, Luthman K, Artursson P. Absorption Classification of Oral Drugs Based on
Molecular Surface Properties. J Med Chem. 46 (2003) 558-570.
Laitinen
N. Opening new perspectives for visual characterisation of pharmaceutical
solids. Doctoral dissertation 2003. University of Helsinki, Faculty of Science,
Department of Pharmacy.
Burton PS, Goodwin JT, Vidmar TJ, Amore BM.
Predicting Drug Absorption: How
Nature Made It a Difficult Problem. J Pharmacol Exp Ther.
303 (2002) 889-895.
Stenberg P, Bergstrom CAS, Luthman K, Artursson
P. Theoretical predictions of drug absorption in drug discovery and development.
Clin Pharmcokinet. 41 (2002) 877-899.
Egan WJ, Lauri G.
Prediction of intestinal permeability. Adv Drug Deliver Rev. 54 (2002)
273-289.
Andersen K, Buur A. Moderne Laegemiddelforskning. Dansk Kemi. 82 (2001)
40-4.
Stenberg P.
Computational models for the prediction of intestinal membrane permeability.
Dissertation. Uppsala University. 2001.
Ohm A. Interaction
of bay t 3839 coprecipitates with insoluble excipients. Eur J Pharm Biopharm.
49 (2000) 183-9.
Stewart BH, Wang Y,
Surendran N. Ex vivo approaches to predicting oral pharmacokinetics in humans.
Annu Rep Med Chem. 35 (2000) 299-307.
Blake JF. Chemoinformatics
– predicting the physicochemical properties of “drug-like” molecules. Curr Opin
Biotech. 11 (2000) 104-7.
Boxenbaum H. Absorption
potential and its variants. Pharm Res. 16 (1999) 1893.
Curatolo W. Physical
chemical properties of oral drug candidates in the discovery and exploratory
development settings. PSTT. 1 (1998) 387-93.
De Vrueh
RLA, Smith PL, Lee
CP. Transport of L-valine-acyclovir via the oligopeptide transporter in the
human intestinal cell line. J Pharmacol Exp Ther. 286 (1998) 1166-70.
Book citations
Johansson
F, Paterson R. Chapter 21 - Physiologically Based in Silico Models for the
Prediction of Oral Drug Absorption. Drug Absorption Studies. ed.
Ehrhardt C, Kim KJ. 2008 Springer ISBN 9780387749006.
van de Waterbeemd
H. Chapter 2 - Physicochemical Properties in Drug Profiling. Molecular
Drug Properties: Measurement and Prediction. Mannhold R. 2007 Wiley-VCH.
ISBN 3527317554.
Tong WQ. Chapter 5 - Practical aspects of solubility determination in
pharmaceutical preformulation. Solvent Systems and Their Selection in
Pharmaceutics and Biopharmaceutics. ed. Augustinjns P, Brewster ME.
2007 American Association of Pharmaceutical Scientists. ISBN 9780387691497.
Brewster ME, Mackie C, Noppe M, Lampo A, Loftsson T. Chapter 8 - The use
of solubilizing excipients and approaches to generate toxicology vehicles for
contemporary drug pipelines. Solvent Systems and Their Selection in
Pharmaceutics and Biopharmaceutics. ed. Augustinjns P, Brewster ME.
2007 American Association of Pharmaceutical Scientists. ISBN 9780387691497.
Li S, Mueller-Zsigmondy M, Yin H. Chapter 4 - The Role of In Vitro-In Vivo
Correlation in Product Development and Life Cycle Management.
Pharmaceutical Product Development In Vitro-In Vivo Correlation. ed.
Chilukuri DM, Sunkara G, Young D. 2007 Informa Health Care. ISBN 0849338271.
Johnson KC. Chapter 1 - Dissolution: Fundamentals of In Vitro Release and
the Biopharmaceutics Classification System. Pharmaceutical Product
Development In Vitro-In Vivo Correlation. ed. Chilukuri DM, Sunkara G,
Young D. 2007 Informa Health Care. ISBN 0849338271.
Petricoul O, Cosson V, Fuseau E, Marchand M. Population models for drug
absorption and enterohepatic recycling. Pharmacometrics The Science of
Quantitative Pharmacology. Ette EI, Williams PJ editors. 2007 John Wiley &
Sons, Inc. ISBN 9780471677833.
van de Waterbeemd H. Property-Based Lead
Optimization.
Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and
Computational Strategies. Testa B, Krämer SD, Wunderli-Allenspach H,
Folkers G editors. 2006 Verlag Helvetica Chimica Acta/Wiley-VCH. ISBN
3906390357.
Avdeef A. High-Throughput Solubility,
Permeability, and the MAD PAMPA Model.
Pharmacokinetic Profiling in Drug Research: Biological, Physicochemical, and
Computational Strategies. Testa B, Krämer SD, Wunderli-Allenspach H,
Folkers G editors. 2006 Verlag Helvetica Chimica Acta/Wiley-VCH. ISBN
3906390357.
Hageman MJ. Chapter 5 - Solubility,
Solubilization and Dissolution in Drug Delivery During Lead Optimization.
Optimizing the "Drug Like" Properties of Leads in Drug Discovery. ed.
Borchardt RT, Kerns EH, Hageman MJ, Thakker DR, Stevens JL. 2006 Springer New
York. ISBN 9780387340562.
Rohrs BR. Chapter 7 - Biopharmaceutics Modeling
and the Role of Dose and Formulation on Oral Exposure.
Optimizing the "Drug Like" Properties of Leads in Drug Discovery. ed.
Borchardt RT, Kerns EH, Hageman MJ, Thakker DR, Stevens JL. 2006 Springer New
York. ISBN 9780387340562.
Di L, Kerns EH. Chapter 8 - Application of
Physicochemical Data to Support Lead Optimization by Discovery Teams.
Optimizing the "Drug Like" Properties of Leads in Drug Discovery. ed.
Borchardt RT, Kerns EH, Hageman MJ, Thakker DR, Stevens JL. 2006 Springer New
York. ISBN 9780387340562.
Burton PS, Poggesi I, Germani M, Goodwin JT.
Chapter 9 - Computational Models Supporting Lead Optimization in Drug
Discovery.
Optimizing the "Drug Like" Properties of Leads in Drug Discovery. ed.
Borchardt RT, Kerns EH, Hageman MJ, Thakker DR, Stevens JL. 2006 Springer New
York. ISBN 9780387340562.
Iliadis A, Macheras P. Modeling in
Biopharmaceutics, Pharmacokinetics and Pharmacodynamics: Homogeneous and
Heterogeneous Approaches. 2006 Springer. ISBN 0387281789.
Chapter 3 - Absorption. Pharmacokinetics and
Metabolism in Drug Design. ed.
Smith DA, van de Waterbeemd, Walker DK. 2006 Wiley-VCH. ISBN 3527313680.
Pudipeddi M, Serajuddin ATM, Mufson D. Chapter 3
- Integrated Drug Product Development-From Lead Candidate Selection to
Life-Cycle Management.
The Process of New Drug Discovery
and Development. Smith CG, O'Donnell JT ed. 2006 Informa Health Care. ISBN 0849327792.
Hilfiker R, Blatter F, von Raumer M. Relevance of solid-state properties
for pharmaceutical products. Polymorphism: in the Pharmaceutical Industry.
ed. Hilfiker R. 2006 Wiley-VCH. ISBN 3527311467.
Quallich GJ, Chapter 12 - Selection of the Drug Form in Exploratory
Development. Fundamentals of Early Clinical Drug Development: From Synthesis
Design to Formulation. ed. Abdel-Magid AF, Caron S. 2006 John Wiley & Sons.
ISBN-10 0471692786.
Sathe PM, Raw AS, Ouderkirk LA, Yu LX,
Hussain AS. Chapter 8 - Drug product performance, In Vitro. Generic Drug Product Development: Solid Oral
Dosage Forms. ed. Shargel L, Kanfer I. 2005 Informa Health Care. ISBN
0824754603.
Lombardo F, Absorption Prediction. Pharmaceutical Profiling in Drug
Discovery For Lead Selection. ed. Borchardt RT, Kerns EH, Lipinski CA,
Thakker DR, Wang B. 2004 Springer. ISBN 0971176795.
van de Waterbeemd H. Chapter 1 - Physico-chemical
Approaches to Drug Absorption. Drug Bioavailability: Estimation of Solubility,
Permeability, Absorption and Bioavailability. ed. van de Waterbeemd H,
Lennernas H, Artursson P. 2003 Wiley-VCH. ISBN 352730438X.
van de Waterbeemd H, Jones BC. Chapter 1 - Predicting Oral Absorption and
Bioavailability. Progress in Medicinal Chemistry Volume 41. ed. King
FD, Oxford AW. 2003 Elsevier Science. ISBN 0444511423.
Granero GE, Ramachandran C, Amidon GL. Chapter 8
- Gastrointestinal Dissolution and Absorption of Drugs. Drug
Bioavailability: Estimation of Solubility, Permeability, Absorption and
Bioavailability. ed. van de Waterbeemd H, Lennernas H, Artursson P. 2003
Wiley-VCH. ISBN 352730438X.
Crison JR. Chapter 5 - Biopharmaceutical Aspects
of Water-Insoluble Drugs for Oral Drug Delivery. Water-Insoluble Drug
Formulation. ed. Liu R. 2000 CRC Press. ISBN 1574911058.
McNamara DP, Vieira ML, Crison JR. Chapter 5 -
Dissolution of Pharmaceuticals in Simple and Complex Systems. Transport
Processes in Pharmaceutical Systems. ed. Amidon GL, Lee PI, Topp EM. 2000
CRC Press. ISBN 0824766105.
Yu LX, Gatlin L, Amidon GL. Chapter 10 -
Predicting Oral Drug Absorption. Transport Processes in Pharmaceutical
Systems. ed. Amidon GL, Lee PI, Topp EM. 2000 CRC Press. ISBN 0824766105.
Inskeep PB, Darrington RT. Chapter 1 - Utilization of biopharmaceutical
and pharmacokinetic principles in the development of veterinary controlled
release drug delivery systems. Controlled Release Veterinary Drug Delivery:
Biological and Pharmaceutical Considerations. ed. Rathbone MJ, Gurny R.
2000 Elsevier Science.
Lombardo F, Winter SM, Tremaine L, Lowe JA III. The anxieties of drug discovery and development.
Integration of Pharmaceutical Discovery and
Development: casehistories. ed. Borchardt RT. 1998 Springer. ISBN
0306457431.
Zhang Y, Johnson KC. Effect of drug particle
size on content uniformity of low-dose solid dosage forms Int J Pharm. 154
(1997) 179-183.
Simons
SJR. Chapter 27 - Liquid Bridges in Granules. Granulation, Volume 11
(Handbook of Powder Technology). Salman AD, Hounslow M, Seville JPK
editors. 2007 Elsevier. ISBN 0444518711.
A.P. Tinke, K.
Vanhoutte, F. Vanhoutte, M. De Smet and H. De Winter Laser
diffraction and image analysis as a supportive analytical tool in the
pharmaceutical development of immediate release direct compression
formulations. Int J Pharm. 297 (2005) 80-8.
Rossetti D,
Simons SJR, Pagliai P, Ward R, Fitzpatrick S. Predicting the performance of
granulation binders through micro-mechanistic observations. Particle &
Particle Systems Characterization. 21 (2004) 284-292.
Simons SJR,
Rossetti D, Pagliai P, Ward R, Fitzpatrick S. Predicting the performance of
granulation binders through micro-mechanistic observations. Powder Technol.
140 (2004) 280-9.
Lee CC, Chan LW,
Heng PW. Use of a fluidized bed
hammer mill for size reduction and classification: effects of process
variables and starting materials on the particle size distribution of milled
lactose batches. Pharm Dev Technol. 8 (2003) 431-42.
Johnson KC. Dissolution and absorption
modeling: model expansion to simulate the effects of precipitation, water
absorption, longitudinally changing intestinal permeability, and controlled
release on drug absorption. Drug Dev Ind Pharm. 29 (2003) 833-42.
Dickhoff BH, de Boer AH, Lambregts D,
Frijlink HW. The effect of carrier surface and bulk properties on drug
particle detachment from crystalline lactose carrier particles during
inhalation, as function of carrier payload and mixing time. Eur J Pharm
Biopharm. 56 (2003) 291-302.
Mullarney MP, Hancock BC, Carlson GT, Ladipo
DD, Langdon BA. The powder flow and compact mechanical properties of sucrose
and three high-intensity sweeteners used in chewable tablets. Int J Pharm.
257 (2003) 227-36.
Kornchankul W, Hamed E,
Parikh NH, Sakr A. Effect of drug proportion and mixing time on the content
uniformity of a low dose drug in a high shear mixer. Pharmazie 57
(2002) 49-53.
Kato Y, Moroshima K,
Hashizume M, et al. Further observation of content uniformity of D-alpha-tocopheryl
acetate as an oily drug in granules obtained by wet granulation with a
high-shear mixer. Drug Dev Ind Pharm. 27 (2001) 781-7.
Prescott JK, Garcia TP. A
solid dosage and blend content uniformity troubleshooting diagram. Pharm
Technol. 25 (2001) 68-88.
Kornchankul W, Parikh NH,
Sakr A. Effect of process variables on the content uniformity of a low dose
drug in a high shear mixer. Pharm Ind. 62 (2000) 305-11.
Book citations
Gibson M. Pharmaceutical Preformulation and
Formulation: A Practical Guide from Candidate Drug Selection to
Commercial Dosage Form. 2004 Informa Health Care. ISBN 1574911201.
Stricker H.
Arzneiformen-Entwicklung. 2003 Springer. ISBN 3540000682.
Carstensen JT. Advanced Pharmaceutical Solids.
2001 CRC Press. ISBN 0824704312.
Johnson KC. Dissolution and absorption
modeling: model expansion to simulate the effects of precipitation, water
absorption, longitudinally changing intestinal permeability, and controlled
release on drug absorption. Drug Dev Ind Pharm. 29 (2003) 833-42.
Pole DL. Physical and biological Considerations for the Use of Nonaqueous
Solvents in Oral Bioavailability Enhancement. J Pharm Sci. 97 (2008)
1071-1088.
Sugano K, Okazaki A, Sugimoto S, Tavornvipas
S, Omura A, Mano T. Solubility and dissolution profile assessment in drug
discovery. Drug Metab Pharmacokinet. 22 (2007) 225-254.
Kallen A. A simple absorption model for
dose-escalating studies. Journal of Pharmacokinetics and Pharmacodynamics.
34 (2007) 251-261.
Stegemann S, Leveiller F, Franchi D, de Jong H,
Linden H. When poor solubility becomes an issue: from early stage to proof of
concept. European Journal of Pharmaceutical Sciences. 31 (2007) 249-261.
Jinno J, Kamada N, Miyake M, Yamada K, Mukai
T, Odomi M, Toguchi H, Liversidge GG, Higaki K, Kimura T. Effect of particle
size reduction on dissolution and oral absorption of a poorly water-soluble
drug, cilostazol, in beagle dogs. J Control Release. 111 (2006) 56-64.
Thombre AG. Assessment of the feasibility of
oral controlled release in an exploratory development setting. Drug Discov
Today. 10 (2005) 1159-66.
Sertsou G.
Analytical derivation of time required for
dissolution of monodisperse drug particles. J Pharm Sci. 93 (2004)
1941-4.
Book citations
Brewster ME, Mackie C, Noppe M, Lampo A, Loftsson T. Chapter 8 - The use of
solubilizing excipients and approaches to generate toxicology vehicles for
contemporary drug pipelines. Solvent Systems and Their Selection in
Pharmaceutics and Biopharmaceutics. ed. Augustinjns P, Brewster ME.
2007 American Association of Pharmaceutical Scientists. ISBN 9780387691497.
Johnson KC. Chapter 1 - Dissolution: Fundamentals of In Vitro Release and
the Biopharmaceutics Classification System. Pharmaceutical Product
Development In Vitro-In Vivo Correlation. ed. Chilukuri DM, Sunkara G,
Young D. 2007 Informa Health Care. ISBN 0849338271.
| 